Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study.
Fiche publication
Date publication
décembre 2023
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Vieujean S, Laharie D, Buisson A, Roblin X, Fumery M, Nancey S, Wils P, Altwegg R, Seidel L, Caron B, Peyrin-Biroulet L
Lien Pubmed
Résumé
While the efficacy of tofacitinib to induce and maintain clinical and endoscopic remission is well established in ulcerative colitis (UC), little is known about its efficacy to induce histological remission.
Mots clés
Histologic remission, Neutrophilic infiltrate, Tofacitinib, Ulcerative colitis
Référence
Dig Liver Dis. 2023 12 7;: